Dominant FGF Autocrine Signaling in Gefitinib-Resistant Non-Small Cell Lung Cancer Cells

被引：0
|
作者：
Heasley, Lynn E. [1 ]
Marek, Lindsay [1 ]
Fritzsche, Alexa [1 ]
Helton, Wallace R. [1 ]
Nemenoff, Raphael A. [2 ]
McDermott, Lee A. [3 ]
Helfrich, Barbara [1 ]
Bunn, Paul A. [1 ]
机构：
[1] UCHSC, Aurora, CO USA
[2] UCHSC, Denver, CO USA
[3] Hoffman La Roche, Nutley, NJ USA
来源：
FASEB JOURNAL | 2008年 / 22卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Inhibiting proliferation of gefitinib-resistant, non-small cell lung cancer
    Makoto Sudo
    Tan Min Chin
    Seiichi Mori
    Ngan B. Doan
    Jonathan W. Said
    Makoto Akashi
    H. Phillip Koeffler
    [J]. Cancer Chemotherapy and Pharmacology, 2013, 71 : 1325 - 1334
  • [2] Inhibiting proliferation of gefitinib-resistant, non-small cell lung cancer
    Sudo, Makoto
    Chin, Tan Min
    Mori, Seiichi
    Doan, Ngan B.
    Said, Jonathan W.
    Akashi, Makoto
    Koeffler, H. Phillip
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (05) : 1325 - 1334
  • [3] Implications of MicroRNAs in the Treatment of Gefitinib-Resistant Non-Small Cell Lung Cancer
    Sin, Thomas K.
    Wang, Fengfeng
    Meng, Fei
    Wong, S. C. Cesar
    Cho, William C. S.
    Siu, Parco M.
    Chan, Lawrence W. C.
    Yung, Benjamin Y. M.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (02)
  • [4] Effect of opioid receptor agonists in gefitinib-resistant non-small cell lung cancer
    Suzuki, Atsuo
    Kuzumaki, Naoko
    Hosoya, Takahiro
    Narita, Michiko
    Tsukiji, Kozue
    Suzuki, Masami
    Uezono, Yasuhito
    Morita, Hiroshi
    Suzuki, Tsutomu
    Narita, Minoru
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2011, 115 : 105P - 105P
  • [5] The Mechanisms of the Growth Inhibitory Effects of Paclitaxel on Gefitinib-resistant Non-small Cell Lung Cancer Cells
    Mohiuddin, Md
    Kasahara, Kazuo
    [J]. CANCER GENOMICS & PROTEOMICS, 2021, 18 (05) : 661 - 673
  • [6] Overexpression and extended degradation rate of Axl in acquired gefitinib-resistant non-small cell lung cancer cells
    Kim, Donghwa
    Bach, Duc-Hiep
    Hong, Ji-Young
    Park, Hyen Joo
    Lee, Sang Kook
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [7] In Vitro and in Vivo Efficacy of NBDHEX on Gefitinib-resistant Human Non-small Cell Lung Cancer
    Sha, Huanhuan
    Dong, Shuchen
    Yu, Chen
    Zou, Renrui
    Zhu, Yue
    Lu, Ya
    Zhang, Junying
    Cao, Haixia
    Chen, Dan
    Wu, Jianzhong
    Feng, Jifeng
    [J]. JOURNAL OF CANCER, 2020, 11 (24): : 7216 - 7223
  • [8] Potential roles of tumor microenvironment in gefitinib-resistant non-small cell lung cancer: A narrative review
    Chen, Mu-Tong
    Li, Bai-Zhi
    Zhang, En-Pu
    Zheng, Qing
    [J]. MEDICINE, 2023, 102 (40) : E35086
  • [9] Clinical Significance of Erlotinib Monotherapy for Gefitinib-resistant Non-small Cell Lung Cancer with EGFR Mutations
    Koyama, Nobuyuki
    Uchida, Yoshitaka
    [J]. ANTICANCER RESEARCH, 2013, 33 (11) : 5083 - 5089
  • [10] Atractyloside inhibits gefitinib-resistant non-small-cell lung cancer cell proliferation
    Yao, Wanxin
    Liu, Chen
    Zhang, Ningyin
    Zhang, Yanmei
    Qian, Yong
    [J]. ONCOLOGY LETTERS, 2024, 28 (04)
12345